Dunvegan Associates
TRAW icon

Dunvegan Associates’s Traws Pharma TRAW Stock Holding History

Dunvegan Associates’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Hold
0
– -$1K – 206
2015
Q3 		– Hold
0
– – – 203
2015
Q2 		– Hold
0
– – – 199
2015
Q1 		– Hold
0
– – – 206
2014
Q4 		– Hold
0
– – – 202
2014
Q3 		– Hold
0
– – – 190
2014
Q2 		– Hold
0
– – – 186
2014
Q1 		– Hold
0
– – – 201

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Weiss Multi-Strategy Advisers
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Douglas C. Lane & Associates
Douglas C. Lane & Associates New York $3.69B AUM 0.11% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return